BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28848075)

  • 1. Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer.
    Wojtczyk-Miaskowska A; Presler M; Michajlowski J; Matuszewski M; Schlichtholz B
    Cell Physiol Biochem; 2017; 42(6):2404-2417. PubMed ID: 28848075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.
    Ma Y; Chen Y; Petersen I
    Pathol Res Pract; 2017 Apr; 213(4):333-338. PubMed ID: 28214209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
    Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of DNA repair gene methylation in blood of chronic fluorosis patients and rats.
    Wu CX; Wang YH; Li Y; Guan ZZ; Qi XL
    J Trace Elem Med Biol; 2018 Dec; 50():223-228. PubMed ID: 30262283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mismatch repair and meiotic recombination endonuclease Mlh1-Mlh3 is activated by polymer formation and can cleave DNA substrates in trans.
    Manhart CM; Ni X; White MA; Ortega J; Surtees JA; Alani E
    PLoS Biol; 2017 Apr; 15(4):e2001164. PubMed ID: 28453523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counteraction of Oxidative Stress by Vitamin E Affects Epigenetic Regulation by Increasing Global Methylation and Gene Expression of
    Zappe K; Pointner A; Switzeny OJ; Magnet U; Tomeva E; Heller J; Mare G; Wagner KH; Knasmueller S; Haslberger AG
    Oxid Med Cell Longev; 2018; 2018():3734250. PubMed ID: 29854080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.
    Stark AM; Doukas A; Hugo HH; Hedderich J; Hattermann K; Maximilian Mehdorn H; Held-Feindt J
    Neurol Res; 2015 Feb; 37(2):95-105. PubMed ID: 24995467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
    Lin YL; Wang YL; Ma JG; Li WP
    J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
    Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
    BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
    Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
    Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer.
    Christoph F; Hinz S; Kempkensteffen C; Weikert S; Krause H; Schostak M; Schrader M; Miller K
    J Cancer Res Clin Oncol; 2007 Jun; 133(6):343-9. PubMed ID: 17160380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
    J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line].
    Lu R; Fang JY; Zhu HY; Chen YX; Cheng ZH; Li EL
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1014-7. PubMed ID: 15312538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.
    Hu H; Chen X; Zhou C; Li B; Yang Y; Ying X; Mao Y; Zhang Y; Zhong J; Dai J; Yu H; Wu B; Li X; Wang T; Duan S
    J Clin Lab Anal; 2018 Jun; 32(5):e22370. PubMed ID: 29205508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung.
    Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L
    Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype.
    Pinto M; Wu Y; Mensink RG; Cirnes L; Seruca R; Hofstra RM
    Cancer Genet Cytogenet; 2008 Jan; 180(2):110-4. PubMed ID: 18206535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of MLH3, MLH1, and MSH4 in maturation arrest.
    Ferrás C; Fernandes S; Silva J; Barros A; Sousa M
    Reprod Sci; 2012 Jun; 19(6):587-96. PubMed ID: 22344730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
    Christoph F; Hinz S; Weikert S; Kempkensteffen C; Schostak M; Miller K; Schrader M
    Urol Int; 2008; 80(4):398-404. PubMed ID: 18587251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
    Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
    Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.